Research Article

Evaluation of vitamin D prescribing and consumption in Turkiye

Volume: 53 Number: 2 August 30, 2023
EN

Evaluation of vitamin D prescribing and consumption in Turkiye

Abstract

Background and Aims: Vitamin D plays several roles in keeping the body’s cells healthy and functioning the way they should. Most people do not get enough Vitamin D, so supplements are common. However, it is also possible for this vitamin to build up and reach toxic levels in the body. This study investigated the prescription of Vitamin D and Analogues in primary care and outpatient consumption in Türkiye between the years 2015- 2018. Also, the number of protocols created with Hypervitaminosis D was evaluated. Methods: In this study, drug consumption data were evaluated by Prescription Information System (PIS) and ATC/DDD (Anatomical, Therapeutic and Chem- Defined Daily Dose) Methodology. Descriptive statistics were used for evaluation of the data, and numerical values were presented via tables and graphics. Statistical analysis of the data was performed using the SPSS 23 (Statistical Package for the Social Sciences) package program. The Chi-square test was used to evaluate the relationship between the variables, and the P value below 0.05 was accepted as a statistical significance. Results: Between 2015 and 2018, a total of 11.874.898 prescriptions containing drugs with the A11CC (Vitamin D and Analogues) ATC code were created by family physicians. The total number and the percentage of prescriptions containing Vitamin D and Analogues increased over these years. There was a statistically significant difference between the number of prescriptions. While the percentage of prescriptions containing Vitamin D and Analogues was 0.89 in 2015, it was 3.38 in 2018. It was determined that the percentage of prescriptions increased over these years. The consumption of the drugs with the A11CC ATC code in outpatients increased over these years according to the ATC/DDD methodology. Conclusion: The study showed that the prescription of preparations containing Vitamin D by family physicians increased significantly over the years and there was an increase in Vitamin D consumption in outpatients. In addition, it was shown that the number of protocols established for the diagnosis of Hypervitaminosis D increased over the years in Türkiye.

Keywords

References

  1. Akılcı İlaç Kullanımı. (2022). Neden Akılcı İlaç Kullanımı. Retrieved from http://www.akilciilac.gov.tr/ google scholar
  2. Aksoy, M., Alkan, A., İşli, F. (2015). Sağlık Bakanlığı’nın Akılcı İlaç Kullanımını Yaygınlaştırma Faaliyetleri. Türkiye Klinikleri, 3(1), 19-26. google scholar
  3. Altieri, B., Cavalier, E., Bhattoa, H. P,, Perez-Lopez, F. R., Lopez-Bae-na, M. T., Perez-Roncero, G. R. (2020). Vitamin D testing: advan-tages and limits of the current assays. European Journal of Clinical Nutrition, 74, 231-247. google scholar
  4. Aydın, A. E., Dokuzlar, Ö. (2018). Geriatrik Bir Olguda D Vitamini İntoksikasyonuna Bağlı Gelişen Akut Mental Değişiklik. Geriatrik Bilimler Dergisi, 1(2), 73-78. google scholar
  5. Balkan, F., Ünal, O. K. (2013). Nadir bir hiperkalsemi sebebi: D vitamini intoksikasyonu. Genel Tıp Dergisi., 23(3), 90-92. google scholar
  6. Belaidi, N., Georges, A., Lacroix, I., Croisonnier, A., Ducros, V., Sou-berbielle, J.C. et al. (2016). Hypercalcemia and elevated concen-tration of Vitamin D: A case report too easy to be true. Clinica Chi-mica Acta; International Journal of Clinical Chemistry, 457, 123-124. google scholar
  7. Bouillon, R., Carmeliet, G. (2018). Vitamin D insufficiency: Defini-tion, diagnosis and management. Best Practice & Research Clinical Endocrinology & Metabolism, 32(5), 669-684. google scholar
  8. Bozacı, İ., Avcı, T., Nalbant, S., Vasi, İ., Soydan, M. (2018). Oral D Vitamin Replasmanına Bağlı Gelişen Hiperkalsemi ve Akut Böbrek Hasarı. Turkish Nephrology Dialysis and Transplantation Journal, 27(2), 221-224. google scholar

Details

Primary Language

English

Subjects

Pharmacology and Pharmaceutical Sciences, Health Care Administration

Journal Section

Research Article

Publication Date

August 30, 2023

Submission Date

October 25, 2022

Acceptance Date

May 23, 2023

Published in Issue

Year 2023 Volume: 53 Number: 2

APA
Varımlı, D., İşli, F., & Ündeğer Bucurgat, Ü. (2023). Evaluation of vitamin D prescribing and consumption in Turkiye. İstanbul Journal of Pharmacy, 53(2), 110-117. https://doi.org/10.26650/IstanbulJPharm.2023.1194407
AMA
1.Varımlı D, İşli F, Ündeğer Bucurgat Ü. Evaluation of vitamin D prescribing and consumption in Turkiye. iujp. 2023;53(2):110-117. doi:10.26650/IstanbulJPharm.2023.1194407
Chicago
Varımlı, Didem, Fatma İşli, and Ülkü Ündeğer Bucurgat. 2023. “Evaluation of Vitamin D Prescribing and Consumption in Turkiye”. İstanbul Journal of Pharmacy 53 (2): 110-17. https://doi.org/10.26650/IstanbulJPharm.2023.1194407.
EndNote
Varımlı D, İşli F, Ündeğer Bucurgat Ü (August 1, 2023) Evaluation of vitamin D prescribing and consumption in Turkiye. İstanbul Journal of Pharmacy 53 2 110–117.
IEEE
[1]D. Varımlı, F. İşli, and Ü. Ündeğer Bucurgat, “Evaluation of vitamin D prescribing and consumption in Turkiye”, iujp, vol. 53, no. 2, pp. 110–117, Aug. 2023, doi: 10.26650/IstanbulJPharm.2023.1194407.
ISNAD
Varımlı, Didem - İşli, Fatma - Ündeğer Bucurgat, Ülkü. “Evaluation of Vitamin D Prescribing and Consumption in Turkiye”. İstanbul Journal of Pharmacy 53/2 (August 1, 2023): 110-117. https://doi.org/10.26650/IstanbulJPharm.2023.1194407.
JAMA
1.Varımlı D, İşli F, Ündeğer Bucurgat Ü. Evaluation of vitamin D prescribing and consumption in Turkiye. iujp. 2023;53:110–117.
MLA
Varımlı, Didem, et al. “Evaluation of Vitamin D Prescribing and Consumption in Turkiye”. İstanbul Journal of Pharmacy, vol. 53, no. 2, Aug. 2023, pp. 110-7, doi:10.26650/IstanbulJPharm.2023.1194407.
Vancouver
1.Didem Varımlı, Fatma İşli, Ülkü Ündeğer Bucurgat. Evaluation of vitamin D prescribing and consumption in Turkiye. iujp. 2023 Aug. 1;53(2):110-7. doi:10.26650/IstanbulJPharm.2023.1194407